
Zepbound
Productby Eli Lilly and Company
Heard in 44 episodes across 27 shows since Oct 2025
Zepbound is a brand name for tirzepatide, an injectable prescription medication developed by Eli Lilly and Company. It is approved for chronic weight management in adults with obesity or who are overweight with weight-related medical conditions.
Discussed inMarkets63%Politics16%Business11%Health & Science11%
Episodes
44
across 27 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of Zepbound per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 29 | 0.01‰ | 1 |
| Sep 13 | 0.02‰ | 2 |
| Sep 17 | 0.04‰ | 2 |
| Sep 23 | 0.03‰ | 1 |
| Sep 30 | 0.02‰ | 2 |
| Oct 3 | 0.04‰ | 2 |
| Oct 5 | 0.04‰ | 1 |
| Oct 6 | 0.05‰ | 1 |
| Oct 20 | 0.02‰ | 2 |
| Oct 22 | 0.02‰ | 1 |
| Oct 28 | 0.02‰ | 1 |
| Oct 29 | 0.04‰ | 4 |
| Oct 30 | 0.05‰ | 1 |
| Oct 31 | 0.06‰ | 1 |
| Nov 1 | 0.08‰ | 2 |
| Nov 2 | 0.08‰ | 1 |
| Nov 5 | 0.05‰ | 1 |
| Nov 8 | 0.02‰ | 1 |
| Nov 9 | 0.04‰ | 3 |
| Nov 10 | 0.05‰ | 1 |
| Nov 17 | 0.02‰ | 2 |
| Nov 18 | 0.02‰ | 1 |
Email alert
Email me when Zepbound comes up on a podcast
One email a week at most, with the new episodes that mention Zepbound. Free, no account needed, unsubscribe in one click.
Episodes
44 episodes featuring Zepbound, newest first
- Nov 18, 2026
Gold falters as Anthropic tests IPO appetiteEquity Mates Investing PodcastNov 18, 2026 - Nov 17, 2026
FAA probes network failure as AI markets resetWSJ What’s NewsNov 17, 2026 - Nov 17, 2026
America’s colleges, chips and culture face a trust testMorning Brew DailyNov 17, 2026 - Nov 10, 2026
Nvidia scrutiny tests corporate accountability and national securityPBS News Hour - Full ShowNov 10, 2026 - Nov 9, 2026
Nvidia stumbles as investors rotate beyond AIClosing BellNov 9, 2026 - Nov 9, 2026
Nvidia’s China exposure collides with national-security scrutinyClosing BellNov 9, 2026